COVID-19 and liver cancer: lost patients and larger tumours

BACKGROUND: Northern England has been experiencing a persistent rise in the number of primary liver cancers, largely driven by an increasing incidence of hepatocellular carcinoma (HCC) secondary to alcohol-related liver disease and non-alcoholic fatty liver disease. Here we review the effect of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Geh, Daniel, Watson, Robyn, Sen, Gourab, French, Jeremy J, Hammond, John, Turner, Paul, Hoare, Tim, Anderson, Kirsty, McNeil, Michael, McPherson, Stuart, Masson, Steven, Dyson, Jessica, Donnelly, Mhairi, MacDougal, Louise, Patel, Preya, Hudson, Mark, Anstee, Quentin M, White, Steven, Robinson, Stuart, Pandanaboyana, Sanjay, Walker, Lucy, McCain, Misti, Bury, Yvonne, Raman, Shreya, Burt, Alastair, Parkinson, Daniel, Haugk, Beate, Darne, Antony, Wadd, Nick, Asghar, Syed, Mariappan, Lavanya, Margetts, Jane, Stenberg, Benjamin, Scott, John, Littler, Peter, Manas, Derek M, Reeves, Helen L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Hepatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9023844/
https://www.ncbi.nlm.nih.gov/pubmed/35450934
http://dx.doi.org/10.1136/bmjgast-2021-000794

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9023844/
https://www.ncbi.nlm.nih.gov/pubmed/35450934
http://dx.doi.org/10.1136/bmjgast-2021-000794

Ejemplares similares